1. Home
  2. AKTX vs BIOX Comparison

AKTX vs BIOX Comparison

Compare AKTX & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

SELL

Current Price

$7.18

Market Cap

15.4M

Sector

Health Care

ML Signal

SELL

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

SELL

Current Price

$0.18

Market Cap

13.3M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
AKTX
BIOX
Founded
N/A
2001
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
13.3M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
AKTX
BIOX
Price
$7.18
$0.18
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $25.50
N/A
AVG Volume (30 Days)
32.2K
★ 212.0K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$59.23
Revenue Next Year
N/A
$34.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.17
52 Week High
$29.32
$1.80

Technical Indicators

Market Signals
Indicator
AKTX
BIOX
Relative Strength Index (RSI) 42.25 33.58
Support Level $5.01 N/A
Resistance Level $9.91 $0.26
Average True Range (ATR) 0.90 0.03
MACD -0.06 -0.00
Stochastic Oscillator 24.25 11.42

Price Performance

Historical Comparison
AKTX
BIOX

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: